AIR Capital
VC Fund
Buenos Aires, Argentina
AIR Capital is an early-stage VC that supports entrepreneurs focused on creating a future of Abundance, Inclusion, and Regeneration.
- Total investments:
- 33
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries AIR Capital invests in
Stages AIR Capital invests in
Countries AIR Capital invests in
Round sizes
Round size
- Seed
- $1.5M–$7.9M
- Pre-Seed
- $20k–$1.2M
- Venture - Series Unknown
- $1M–$6.8M
Investment Focus
Industry
- Biotechnology 12 (36%)
- Life Science 4 (12%)
- Health Care 3 (9%)
- Food and Beverage 3 (9%)
- Artificial Intelligence 3 (9%)
Stage
- Seed 15 (45%)
- Venture - Series Unknown 10 (30%)
- Pre-Seed 5 (15%)
- Series A 1 (3%)
Country
- Argentina 13 (39%)
- United States 11 (33%)
- Chile 1 (3%)
- Brazil 1 (3%)
- Israel 1 (3%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Giraffe Bio is a developer of biomolecular technology to improve efficiency and sustainability in critical mineral extraction. The company’s platform customizes biomolecules to each mine’s unique geology, enhancing metal recovery, reducing water use, and minimizing environmental impact. | $6.4M / Seed / Oct 13, 2026 | ||
| Changing the game in how the world deals with diseases in plants, animals, and humans, metaBIX Biotech leads with innovation in disease prediction. Our integrated solution, combining the latest in biotechnology, AI, and advanced software, not only anticipates the impact of viruses and bacteria but also offers proactive strategies to preventoutbreaks. With a focus on precision and speed, we stand out for our ability to provide early alerts and effective control measures, significantly reducing the risk and impact of diseases in our ecosystems and communities. | $1.3M / Venture - Series Unknown / Mar 09, 2026 | ||
| Changing the game in how the world deals with diseases in plants, animals, and humans, metaBIX Biotech leads with innovation in disease prediction. Our integrated solution, combining the latest in biotechnology, AI, and advanced software, not only anticipates the impact of viruses and bacteria but also offers proactive strategies to preventoutbreaks. With a focus on precision and speed, we stand out for our ability to provide early alerts and effective control measures, significantly reducing the risk and impact of diseases in our ecosystems and communities. | $1M / Venture - Series Unknown / Sep 30, 2025 | ||
| ounded in 2022, Calice is at the forefront of agricultural innovation. We specialize in computationally modeling biological and agronomic data of crops to predict and enhance their yield, quality, and adaptability across diverse environmental scenarios.Our flagship software, NODES™, leverages advanced artificial intelligence, data science, andbioinformatics to transform vast amounts of crop data into actionable insights. This enables agricultural companies to optimize their R&D programs, reducing costs, enhancing efficiency, and minimizing environmental impact.At Calice, we believe that the future of agriculture lies in harnessing the power of science and technology to create sustainable and resilient farming practices. Our mission is to contribute to a more sustainable world by helping our clients develop better crops and products, ensuring that natural and productive resources are universally accessible.Join us as we lead the next revolution in agriculture, fostering growth and resilience for a more prosperous and environmentally conscious future. | $441.7K / Seed / May 03, 2025 | ||
| Oncoliq is a startup that is developing a screening method for early cancer detection based on liquid biopsy using a small blood sample. Our technology is based on the detection of panels of microRNAs by PCR and machine learning. | $2.8M / Seed / Apr 01, 2025 | ||
| Giraffe Bio is a developer of biomolecular technology to improve efficiency and sustainability in critical mineral extraction. The company’s platform customizes biomolecules to each mine’s unique geology, enhancing metal recovery, reducing water use, and minimizing environmental impact. | $1.2M / Pre-Seed / Dec 19, 2024 | ||
| Ergo Bioscience is a biotech start-up that focuses on the precise fermentation of plant cells to produce essential, intricate animal proteins. Their goal is to reinvent and revolutionize the food sector by providing innovative and environmentally friendly solutions, in conjunction with science and nature. They start their procedure by identifyingproteins involved in producing the flavors, aroma, color, and texture of foods having an animal origin. Myoglobin and casein are these. | Venture - Series Unknown / Oct 31, 2024 | ||
| Stealth space company | $7.9M / Seed / Oct 03, 2024 | ||
| ounded in 2022, Calice is at the forefront of agricultural innovation. We specialize in computationally modeling biological and agronomic data of crops to predict and enhance their yield, quality, and adaptability across diverse environmental scenarios.Our flagship software, NODES™, leverages advanced artificial intelligence, data science, andbioinformatics to transform vast amounts of crop data into actionable insights. This enables agricultural companies to optimize their R&D programs, reducing costs, enhancing efficiency, and minimizing environmental impact.At Calice, we believe that the future of agriculture lies in harnessing the power of science and technology to create sustainable and resilient farming practices. Our mission is to contribute to a more sustainable world by helping our clients develop better crops and products, ensuring that natural and productive resources are universally accessible.Join us as we lead the next revolution in agriculture, fostering growth and resilience for a more prosperous and environmentally conscious future. | $1.5M / Seed / Sep 01, 2024 | ||
| Ethos Space Resources is a company that operates in the space industry. It specializes in providing in-space propellant refueling and ground services for the emerging space economy, especially for the Starship vehicle developed by SpaceX. It also aims to support the deployment of a planetary sunshade, a geoengineering project that would cool Earthby reducing the amount of sunlight reaching the surface. | Seed / Aug 01, 2024 | ||
| See all 33 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does AIR Capital invest in?
AIR Capital invests primarily in Biotechnology, Life Science and Health Care startups, most often at Seed and Venture - Series Unknown stage. Most of the 33 investments tracked by Shizune back companies in Argentina. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What round sizes does AIR Capital invest in?
AIR Capital typically joins rounds of $1.5M–$7.9M at Seed, $20k–$1.2M at Pre-Seed and $1M–$6.8M at Venture - Series Unknown. These are whole funding-round sizes, not AIR Capital's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds AIR Capital took part in.
When did AIR Capital last invest?
The most recent investment recorded for AIR Capital closed in Oct 2026. Shizune tracks 33 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
